BioDelivery Sciences International Inc (BDSI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The companys marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc (BDSI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioDelivery Sciences International Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 11
Licensing Agreements 12
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 12
BioDelivery Sciences Enters Into Licensing Agreement With Arcion For Topical Clonidine Gel 13
Equity Offering 15
BioDelivery Sciences Raises USD50 Million Private Placement of Preferred Shares 15
BioDelivery Sciences Completes Private Placement Of Shares For US$60 Million 17
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million 18
BioDelivery Sciences International Inc - Key Competitors 20
BioDelivery Sciences International Inc - Key Employees 21
BioDelivery Sciences International Inc - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 10, 2018: BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update 23
Mar 16, 2018: BioDelivery Sciences Announces Fourth Quarter and Full-Year 2017 Financial Results 24
Nov 09, 2017: BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update 26
Aug 09, 2017: BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update 28
May 15, 2017: BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 30
Mar 17, 2017: BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 32
Corporate Communications 35
May 07, 2018: BioDelivery Sciences Names Herm Cukier As Chief Executive Officer 35
Aug 23, 2017: BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables

List of Tables
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDelivery Sciences International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioDelivery Sciences International Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 11
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 12
BioDelivery Sciences Enters Into Licensing Agreement With Arcion For Topical Clonidine Gel 13
BioDelivery Sciences Raises USD50 Million Private Placement of Preferred Shares 15
BioDelivery Sciences Completes Private Placement Of Shares For US$60 Million 17
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million 18
BioDelivery Sciences International Inc, Key Competitors 20
BioDelivery Sciences International Inc, Key Employees 21
BioDelivery Sciences International Inc, Subsidiaries 22

List Of Figures

List of Figures
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioDelivery Sciences International Inc, Medical Devices Deals, 2012 to YTD 2018 9

BioDelivery Sciences International Inc (BDSI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The companys marketed products include fentanyl

USD 250 View Report

BioDelivery Sciences International Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

BioDelivery Sciences International Inc Company Profile is a detailed strategic and analytical report on BioDelivery Sciences International Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

BioDelivery Sciences International Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

BioDelivery Sciences International Inc Company Profile is a detailed strategic and analytical report on BioDelivery Sciences International Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

BioDelivery Sciences International Inc Strategic Analysis Review- BioDelivery Sciences International Inc SWOT, Outlook, Operations and Financial Profile

BioDelivery Sciences International Inc Company Profile provides strategic analysis of BioDelivery Sciences International Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available